LymphedemaV1, PascalFrancis, Corpus, bibRecord, 000556

Lymphödem bei Mammakarzinom : Regionale Konsensus-Empfehlungen zum postoperativen Management, Prävention, Therapie und Nachsorge

Identifieur interne : 000556 ( PascalFrancis/Corpus ); précédent : 000555; suivant : 000557

Lymphödem bei Mammakarzinom : Regionale Konsensus-Empfehlungen zum postoperativen Management, Prävention, Therapie und Nachsorge

Auteurs : U.-S. Albert ; U. Seifart ; M.-E. Heim ; J. Hübner ; W. Jungkunz ; R. Prokein ; O. Rick ; M. Hoffmann ; R. Engenhart-Cabillic ; I. Kopp ; U. Wagner ; M. Kalder

Source :

Geburtshilfe und Frauenheilkunde [ 0016-5751 ] ; 2005.

RBID : Pascal:06-0003695

Descripteurs français

Pascal (Inist)
- Lymphoedème, Tumeur maligne, Régional, Glande mammaire pathologie, Consensus, Recommandation, Postopératoire, Traitement, Conduite à tenir, Prévention, Surveillance, Soin, Gynécologie, Obstétrique, Cancer sein.

English descriptors

KwdEn :
- Breast cancer, Care, Clinical management, Consensus, Gynecology, Lymphedema, Malignant tumor, Mammary gland diseases, Obstetrics, Postoperative, Prevention, Recommendation, Regional, Surveillance, Treatment.

Abstract

Purpose: Secondary lymphedema is one of the most frequent long-term side effects affecting up to 30% of all breast cancer patients after local surgical and radiation treatment. The distruction of the lymphatic system results in a progressive and chronic condition with functional impairments and disabilities limiting patients in their daily activities and involving nearly all aspects of their quality of life. The need to improve oncological management to achieve early diagnosis and referral for effective treatment of lymphedema is a major goal of breast cancer health care while survival improves. Method: A systematic consensus process was carried out involving all relevant partners and providers of lymphedema health care to develop a practical documentation concept and make recommendations based on the evidence of clinical studies and current available guidelines. Results: A practical concept for documentation with defined assessment points including the assessment of quality of life parameters with recognised instruments by the patient herself for evaluation and monitoring of lymphedema was developed. Consensus recommendations for the postoperative management, prevention, treatment and follow-up of breast cancer patients together with a clinical algorithm for in- and outpatient care were finalized. Conclusion: With improved survival long-term side effects with a major impact on quality of life become an important endpoint criteria of oncological treatment. The clearly defined documentation concept and the comprehensive recommendations for lymphedema management may assist clinicians and patients to make timely decisions about in- and outpatient health care practice. Patients' compliance with treatment and prevention routines will be as important as ensuring the continuity of care. A longitudinal prospective study evaluating the effectiveness and efficacy of the consensus recommendation is currently being implemented.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0016-5751`
A02	`01`			`@0 GEFRA2`
A03		`1`		`@0 Geburtshilfe Frauenheilkd.`
A05				`@2 65`
A06				`@2 10`
A08	`01`	`1`	`GER`	`@1 Lymphödem bei Mammakarzinom : Regionale Konsensus-Empfehlungen zum postoperativen Management, Prävention, Therapie und Nachsorge`
A11	`01`	`1`		`@1 ALBERT (U.-S.)`
A11	`02`	`1`		`@1 SEIFART (U.)`
A11	`03`	`1`		`@1 HEIM (M.-E.)`
A11	`04`	`1`		`@1 HÜBNER (J.)`
A11	`05`	`1`		`@1 JUNGKUNZ (W.)`
A11	`06`	`1`		`@1 PROKEIN (R.)`
A11	`07`	`1`		`@1 RICK (O.)`
A11	`08`	`1`		`@1 HOFFMANN (M.)`
A11	`09`	`1`		`@1 ENGENHART-CABILLIC (R.)`
A11	`10`	`1`		`@1 KOPP (I.)`
A11	`11`	`1`		`@1 WAGNER (U.)`
A11	`12`	`1`		`@1 KALDER (M.)`
A14	`01`			`@1 Klinik für Gynäkologie, gynäkologische Endokrinologie und Onkologie, Brustzentrum Regio, Universitätsklinikum Giessen und Marburg @3 DEU @Z 1 aut. @Z 11 aut. @Z 12 aut.`
A14	`02`			`@1 Rehabilitations -Klinik Bellevue @2 Bad Soden Salmünster @3 DEU @Z 2 aut.`
A14	`03`			`@1 Sonnenberg-Klinik, Sooden-Allendorf @3 DEU @Z 3 aut.`
A14	`04`			`@1 Habichtswald-Klinik @2 Kassel @3 DEU @Z 4 aut.`
A14	`05`			`@1 Qualitätszirkel Lymphologie Hessen, Leiter des Arbeitskreises Qualitätszirkel der Deutschen Gesellschaft für Lymphologie @2 Friedberg @3 DEU @Z 5 aut.`
A14	`06`			`@1 HELIOS William Harvey Klinik @2 Bad Nauheim @3 DEU @Z 6 aut.`
A14	`07`			`@1 Klinik Reinhardshöhe @2 Bad Wildungen @3 DEU @Z 7 aut.`
A14	`08`			`@1 DRK Krankenhaus @2 Biedenkopf @3 DEU @Z 8 aut.`
A14	`09`			`@1 Klinik für Strahlentherapie, Universitätsklinikum Giessen und Marburg @3 DEU @Z 9 aut.`
A14	`10`			`@1 Ständige Leitlinien Kommission der Arbeitsgemeinschaft Medizinisch Wissenschaftlicher Fachgesellschaften @3 DEU @Z 10 aut.`
A20				`@1 955-965`
A21				`@1 2005`
A23	`01`			`@0 GER`
A24	`01`			`@0 eng`
A43	`01`			`@1 INIST @2 4872 @5 354000135488220040`
A44				`@0 0000 @1 © 2006 INIST-CNRS. All rights reserved.`
A45				`@0 78 ref.`
A47	`01`	`1`		`@0 06-0003695`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Geburtshilfe und Frauenheilkunde`
A66	`01`			`@0 DEU`
A68	`01`	`1`	`ENG`	`@1 Lymphedema after breast cancer : Regional consensus recommendations for postoperative management, prevention, treatment and follow-up care`
C01	`01`		`ENG`	@0 Purpose: Secondary lymphedema is one of the most frequent long-term side effects affecting up to 30% of all breast cancer patients after local surgical and radiation treatment. The distruction of the lymphatic system results in a progressive and chronic condition with functional impairments and disabilities limiting patients in their daily activities and involving nearly all aspects of their quality of life. The need to improve oncological management to achieve early diagnosis and referral for effective treatment of lymphedema is a major goal of breast cancer health care while survival improves. Method: A systematic consensus process was carried out involving all relevant partners and providers of lymphedema health care to develop a practical documentation concept and make recommendations based on the evidence of clinical studies and current available guidelines. Results: A practical concept for documentation with defined assessment points including the assessment of quality of life parameters with recognised instruments by the patient herself for evaluation and monitoring of lymphedema was developed. Consensus recommendations for the postoperative management, prevention, treatment and follow-up of breast cancer patients together with a clinical algorithm for in- and outpatient care were finalized. Conclusion: With improved survival long-term side effects with a major impact on quality of life become an important endpoint criteria of oncological treatment. The clearly defined documentation concept and the comprehensive recommendations for lymphedema management may assist clinicians and patients to make timely decisions about in- and outpatient health care practice. Patients' compliance with treatment and prevention routines will be as important as ensuring the continuity of care. A longitudinal prospective study evaluating the effectiveness and efficacy of the consensus recommendation is currently being implemented.
C02	`01`	`X`		`@0 002B20E02`
C02	`02`	`X`		`@0 002B12B04`
C03	`01`	`X`	`FRE`	`@0 Lymphoedème @5 01`
C03	`01`	`X`	`ENG`	`@0 Lymphedema @5 01`
C03	`01`	`X`	`SPA`	`@0 Linfedema @5 01`
C03	`02`	`X`	`FRE`	`@0 Tumeur maligne @5 02`
C03	`02`	`X`	`ENG`	`@0 Malignant tumor @5 02`
C03	`02`	`X`	`SPA`	`@0 Tumor maligno @5 02`
C03	`03`	`X`	`FRE`	`@0 Régional @5 03`
C03	`03`	`X`	`ENG`	`@0 Regional @5 03`
C03	`03`	`X`	`SPA`	`@0 Regional @5 03`
C03	`04`	`X`	`FRE`	`@0 Glande mammaire pathologie @2 NM @5 04`
C03	`04`	`X`	`ENG`	`@0 Mammary gland diseases @2 NM @5 04`
C03	`04`	`X`	`SPA`	`@0 Glándula mamaria patología @2 NM @5 04`
C03	`05`	`X`	`FRE`	`@0 Consensus @5 05`
C03	`05`	`X`	`ENG`	`@0 Consensus @5 05`
C03	`05`	`X`	`SPA`	`@0 Consenso @5 05`
C03	`06`	`X`	`FRE`	`@0 Recommandation @5 06`
C03	`06`	`X`	`ENG`	`@0 Recommendation @5 06`
C03	`06`	`X`	`SPA`	`@0 Recomendación @5 06`
C03	`07`	`X`	`FRE`	`@0 Postopératoire @5 08`
C03	`07`	`X`	`ENG`	`@0 Postoperative @5 08`
C03	`07`	`X`	`SPA`	`@0 Postoperatorio @5 08`
C03	`08`	`X`	`FRE`	`@0 Traitement @5 09`
C03	`08`	`X`	`ENG`	`@0 Treatment @5 09`
C03	`08`	`X`	`SPA`	`@0 Tratamiento @5 09`
C03	`09`	`X`	`FRE`	`@0 Conduite à tenir @5 11`
C03	`09`	`X`	`ENG`	`@0 Clinical management @5 11`
C03	`09`	`X`	`SPA`	`@0 Actitud médica @5 11`
C03	`10`	`X`	`FRE`	`@0 Prévention @5 12`
C03	`10`	`X`	`ENG`	`@0 Prevention @5 12`
C03	`10`	`X`	`SPA`	`@0 Prevención @5 12`
C03	`11`	`X`	`FRE`	`@0 Surveillance @5 17`
C03	`11`	`X`	`ENG`	`@0 Surveillance @5 17`
C03	`11`	`X`	`SPA`	`@0 Vigilancia @5 17`
C03	`12`	`X`	`FRE`	`@0 Soin @5 18`
C03	`12`	`X`	`ENG`	`@0 Care @5 18`
C03	`12`	`X`	`SPA`	`@0 Cuidado @5 18`
C03	`13`	`X`	`FRE`	`@0 Gynécologie @5 19`
C03	`13`	`X`	`ENG`	`@0 Gynecology @5 19`
C03	`13`	`X`	`SPA`	`@0 Ginecología @5 19`
C03	`14`	`X`	`FRE`	`@0 Obstétrique @5 20`
C03	`14`	`X`	`ENG`	`@0 Obstetrics @5 20`
C03	`14`	`X`	`SPA`	`@0 Obstétrico @5 20`
C03	`15`	`X`	`FRE`	`@0 Cancer sein @4 CD @5 96`
C03	`15`	`X`	`ENG`	`@0 Breast cancer @4 CD @5 96`
C03	`15`	`X`	`SPA`	`@0 Cáncer pecho @4 CD @5 96`
C07	`01`	`X`	`FRE`	`@0 Appareil circulatoire pathologie @5 37`
C07	`01`	`X`	`ENG`	`@0 Cardiovascular disease @5 37`
C07	`01`	`X`	`SPA`	`@0 Aparato circulatorio patología @5 37`
C07	`02`	`X`	`FRE`	`@0 Lymphatique pathologie @5 38`
C07	`02`	`X`	`ENG`	`@0 Lymphatic vessel disease @5 38`
C07	`02`	`X`	`SPA`	`@0 Linfático patología @5 38`
N21				`@1 002`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Format Inist (serveur)

NO :	PASCAL 06-0003695 INIST
ET :	(Lymphedema after breast cancer : Regional consensus recommendations for postoperative management, prevention, treatment and follow-up care)
GT :	Lymphödem bei Mammakarzinom : Regionale Konsensus-Empfehlungen zum postoperativen Management, Prävention, Therapie und Nachsorge
AU :	ALBERT (U.-S.); SEIFART (U.); HEIM (M.-E.); HÜBNER (J.); JUNGKUNZ (W.); PROKEIN (R.); RICK (O.); HOFFMANN (M.); ENGENHART-CABILLIC (R.); KOPP (I.); WAGNER (U.); KALDER (M.)
AF :	Klinik für Gynäkologie, gynäkologische Endokrinologie und Onkologie, Brustzentrum Regio, Universitätsklinikum Giessen und Marburg/Allemagne (1 aut., 11 aut., 12 aut.); Rehabilitations -Klinik Bellevue/Bad Soden Salmünster/Allemagne (2 aut.); Sonnenberg-Klinik, Sooden-Allendorf/Allemagne (3 aut.); Habichtswald-Klinik/Kassel/Allemagne (4 aut.); Qualitätszirkel Lymphologie Hessen, Leiter des Arbeitskreises Qualitätszirkel der Deutschen Gesellschaft für Lymphologie/Friedberg/Allemagne (5 aut.); HELIOS William Harvey Klinik/Bad Nauheim/Allemagne (6 aut.); Klinik Reinhardshöhe/Bad Wildungen/Allemagne (7 aut.); DRK Krankenhaus/Biedenkopf/Allemagne (8 aut.); Klinik für Strahlentherapie, Universitätsklinikum Giessen und Marburg/Allemagne (9 aut.); Ständige Leitlinien Kommission der Arbeitsgemeinschaft Medizinisch Wissenschaftlicher Fachgesellschaften/Allemagne (10 aut.)
DT :	Publication en série; Niveau analytique
SO :	Geburtshilfe und Frauenheilkunde; ISSN 0016-5751; Coden GEFRA2; Allemagne; Da. 2005; Vol. 65; No. 10; Pp. 955-965; Abs. anglais; Bibl. 78 ref.
LA :	Allemand
EA :	Purpose: Secondary lymphedema is one of the most frequent long-term side effects affecting up to 30% of all breast cancer patients after local surgical and radiation treatment. The distruction of the lymphatic system results in a progressive and chronic condition with functional impairments and disabilities limiting patients in their daily activities and involving nearly all aspects of their quality of life. The need to improve oncological management to achieve early diagnosis and referral for effective treatment of lymphedema is a major goal of breast cancer health care while survival improves. Method: A systematic consensus process was carried out involving all relevant partners and providers of lymphedema health care to develop a practical documentation concept and make recommendations based on the evidence of clinical studies and current available guidelines. Results: A practical concept for documentation with defined assessment points including the assessment of quality of life parameters with recognised instruments by the patient herself for evaluation and monitoring of lymphedema was developed. Consensus recommendations for the postoperative management, prevention, treatment and follow-up of breast cancer patients together with a clinical algorithm for in- and outpatient care were finalized. Conclusion: With improved survival long-term side effects with a major impact on quality of life become an important endpoint criteria of oncological treatment. The clearly defined documentation concept and the comprehensive recommendations for lymphedema management may assist clinicians and patients to make timely decisions about in- and outpatient health care practice. Patients' compliance with treatment and prevention routines will be as important as ensuring the continuity of care. A longitudinal prospective study evaluating the effectiveness and efficacy of the consensus recommendation is currently being implemented.
CC :	002B20E02; 002B12B04
FD :	Lymphoedème; Tumeur maligne; Régional; Glande mammaire pathologie; Consensus; Recommandation; Postopératoire; Traitement; Conduite à tenir; Prévention; Surveillance; Soin; Gynécologie; Obstétrique; Cancer sein
FG :	Appareil circulatoire pathologie; Lymphatique pathologie
ED :	Lymphedema; Malignant tumor; Regional; Mammary gland diseases; Consensus; Recommendation; Postoperative; Treatment; Clinical management; Prevention; Surveillance; Care; Gynecology; Obstetrics; Breast cancer
EG :	Cardiovascular disease; Lymphatic vessel disease
SD :	Linfedema; Tumor maligno; Regional; Glándula mamaria patología; Consenso; Recomendación; Postoperatorio; Tratamiento; Actitud médica; Prevención; Vigilancia; Cuidado; Ginecología; Obstétrico; Cáncer pecho
LO :	INIST-4872.354000135488220040
ID :	06-0003695

Links to Exploration step

Pascal:06-0003695

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="GER" level="a">Lymphödem bei Mammakarzinom : Regionale Konsensus-Empfehlungen zum postoperativen Management, Prävention, Therapie und Nachsorge</title>
<author><name sortKey="Albert, U S" sort="Albert, U S" uniqKey="Albert U" first="U.-S." last="Albert">U.-S. Albert</name>
<affiliation><inist:fA14 i1="01"><s1>Klinik für Gynäkologie, gynäkologische Endokrinologie und Onkologie, Brustzentrum Regio, Universitätsklinikum Giessen und Marburg</s1>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Seifart, U" sort="Seifart, U" uniqKey="Seifart U" first="U." last="Seifart">U. Seifart</name>
<affiliation><inist:fA14 i1="02"><s1>Rehabilitations -Klinik Bellevue</s1>
<s2>Bad Soden Salmünster</s2>
<s3>DEU</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Heim, M E" sort="Heim, M E" uniqKey="Heim M" first="M.-E." last="Heim">M.-E. Heim</name>
<affiliation><inist:fA14 i1="03"><s1>Sonnenberg-Klinik, Sooden-Allendorf</s1>
<s3>DEU</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hubner, J" sort="Hubner, J" uniqKey="Hubner J" first="J." last="Hübner">J. Hübner</name>
<affiliation><inist:fA14 i1="04"><s1>Habichtswald-Klinik</s1>
<s2>Kassel</s2>
<s3>DEU</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Jungkunz, W" sort="Jungkunz, W" uniqKey="Jungkunz W" first="W." last="Jungkunz">W. Jungkunz</name>
<affiliation><inist:fA14 i1="05"><s1>Qualitätszirkel Lymphologie Hessen, Leiter des Arbeitskreises Qualitätszirkel der Deutschen Gesellschaft für Lymphologie</s1>
<s2>Friedberg</s2>
<s3>DEU</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Prokein, R" sort="Prokein, R" uniqKey="Prokein R" first="R." last="Prokein">R. Prokein</name>
<affiliation><inist:fA14 i1="06"><s1>HELIOS William Harvey Klinik</s1>
<s2>Bad Nauheim</s2>
<s3>DEU</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Rick, O" sort="Rick, O" uniqKey="Rick O" first="O." last="Rick">O. Rick</name>
<affiliation><inist:fA14 i1="07"><s1>Klinik Reinhardshöhe</s1>
<s2>Bad Wildungen</s2>
<s3>DEU</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hoffmann, M" sort="Hoffmann, M" uniqKey="Hoffmann M" first="M." last="Hoffmann">M. Hoffmann</name>
<affiliation><inist:fA14 i1="08"><s1>DRK Krankenhaus</s1>
<s2>Biedenkopf</s2>
<s3>DEU</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Engenhart Cabillic, R" sort="Engenhart Cabillic, R" uniqKey="Engenhart Cabillic R" first="R." last="Engenhart-Cabillic">R. Engenhart-Cabillic</name>
<affiliation><inist:fA14 i1="09"><s1>Klinik für Strahlentherapie, Universitätsklinikum Giessen und Marburg</s1>
<s3>DEU</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kopp, I" sort="Kopp, I" uniqKey="Kopp I" first="I." last="Kopp">I. Kopp</name>
<affiliation><inist:fA14 i1="10"><s1>Ständige Leitlinien Kommission der Arbeitsgemeinschaft Medizinisch Wissenschaftlicher Fachgesellschaften</s1>
<s3>DEU</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Wagner, U" sort="Wagner, U" uniqKey="Wagner U" first="U." last="Wagner">U. Wagner</name>
<affiliation><inist:fA14 i1="01"><s1>Klinik für Gynäkologie, gynäkologische Endokrinologie und Onkologie, Brustzentrum Regio, Universitätsklinikum Giessen und Marburg</s1>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kalder, M" sort="Kalder, M" uniqKey="Kalder M" first="M." last="Kalder">M. Kalder</name>
<affiliation><inist:fA14 i1="01"><s1>Klinik für Gynäkologie, gynäkologische Endokrinologie und Onkologie, Brustzentrum Regio, Universitätsklinikum Giessen und Marburg</s1>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">06-0003695</idno>
<date when="2005">2005</date>
<idno type="stanalyst">PASCAL 06-0003695 INIST</idno>
<idno type="RBID">Pascal:06-0003695</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000556</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="GER" level="a">Lymphödem bei Mammakarzinom : Regionale Konsensus-Empfehlungen zum postoperativen Management, Prävention, Therapie und Nachsorge</title>
<author><name sortKey="Albert, U S" sort="Albert, U S" uniqKey="Albert U" first="U.-S." last="Albert">U.-S. Albert</name>
<affiliation><inist:fA14 i1="01"><s1>Klinik für Gynäkologie, gynäkologische Endokrinologie und Onkologie, Brustzentrum Regio, Universitätsklinikum Giessen und Marburg</s1>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Seifart, U" sort="Seifart, U" uniqKey="Seifart U" first="U." last="Seifart">U. Seifart</name>
<affiliation><inist:fA14 i1="02"><s1>Rehabilitations -Klinik Bellevue</s1>
<s2>Bad Soden Salmünster</s2>
<s3>DEU</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Heim, M E" sort="Heim, M E" uniqKey="Heim M" first="M.-E." last="Heim">M.-E. Heim</name>
<affiliation><inist:fA14 i1="03"><s1>Sonnenberg-Klinik, Sooden-Allendorf</s1>
<s3>DEU</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hubner, J" sort="Hubner, J" uniqKey="Hubner J" first="J." last="Hübner">J. Hübner</name>
<affiliation><inist:fA14 i1="04"><s1>Habichtswald-Klinik</s1>
<s2>Kassel</s2>
<s3>DEU</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Jungkunz, W" sort="Jungkunz, W" uniqKey="Jungkunz W" first="W." last="Jungkunz">W. Jungkunz</name>
<affiliation><inist:fA14 i1="05"><s1>Qualitätszirkel Lymphologie Hessen, Leiter des Arbeitskreises Qualitätszirkel der Deutschen Gesellschaft für Lymphologie</s1>
<s2>Friedberg</s2>
<s3>DEU</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Prokein, R" sort="Prokein, R" uniqKey="Prokein R" first="R." last="Prokein">R. Prokein</name>
<affiliation><inist:fA14 i1="06"><s1>HELIOS William Harvey Klinik</s1>
<s2>Bad Nauheim</s2>
<s3>DEU</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Rick, O" sort="Rick, O" uniqKey="Rick O" first="O." last="Rick">O. Rick</name>
<affiliation><inist:fA14 i1="07"><s1>Klinik Reinhardshöhe</s1>
<s2>Bad Wildungen</s2>
<s3>DEU</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hoffmann, M" sort="Hoffmann, M" uniqKey="Hoffmann M" first="M." last="Hoffmann">M. Hoffmann</name>
<affiliation><inist:fA14 i1="08"><s1>DRK Krankenhaus</s1>
<s2>Biedenkopf</s2>
<s3>DEU</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Engenhart Cabillic, R" sort="Engenhart Cabillic, R" uniqKey="Engenhart Cabillic R" first="R." last="Engenhart-Cabillic">R. Engenhart-Cabillic</name>
<affiliation><inist:fA14 i1="09"><s1>Klinik für Strahlentherapie, Universitätsklinikum Giessen und Marburg</s1>
<s3>DEU</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kopp, I" sort="Kopp, I" uniqKey="Kopp I" first="I." last="Kopp">I. Kopp</name>
<affiliation><inist:fA14 i1="10"><s1>Ständige Leitlinien Kommission der Arbeitsgemeinschaft Medizinisch Wissenschaftlicher Fachgesellschaften</s1>
<s3>DEU</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Wagner, U" sort="Wagner, U" uniqKey="Wagner U" first="U." last="Wagner">U. Wagner</name>
<affiliation><inist:fA14 i1="01"><s1>Klinik für Gynäkologie, gynäkologische Endokrinologie und Onkologie, Brustzentrum Regio, Universitätsklinikum Giessen und Marburg</s1>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kalder, M" sort="Kalder, M" uniqKey="Kalder M" first="M." last="Kalder">M. Kalder</name>
<affiliation><inist:fA14 i1="01"><s1>Klinik für Gynäkologie, gynäkologische Endokrinologie und Onkologie, Brustzentrum Regio, Universitätsklinikum Giessen und Marburg</s1>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Geburtshilfe und Frauenheilkunde</title>
<title level="j" type="abbreviated">Geburtshilfe Frauenheilkd.</title>
<idno type="ISSN">0016-5751</idno>
<imprint><date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Geburtshilfe und Frauenheilkunde</title>
<title level="j" type="abbreviated">Geburtshilfe Frauenheilkd.</title>
<idno type="ISSN">0016-5751</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Breast cancer</term>
<term>Care</term>
<term>Clinical management</term>
<term>Consensus</term>
<term>Gynecology</term>
<term>Lymphedema</term>
<term>Malignant tumor</term>
<term>Mammary gland diseases</term>
<term>Obstetrics</term>
<term>Postoperative</term>
<term>Prevention</term>
<term>Recommendation</term>
<term>Regional</term>
<term>Surveillance</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Lymphoedème</term>
<term>Tumeur maligne</term>
<term>Régional</term>
<term>Glande mammaire pathologie</term>
<term>Consensus</term>
<term>Recommandation</term>
<term>Postopératoire</term>
<term>Traitement</term>
<term>Conduite à tenir</term>
<term>Prévention</term>
<term>Surveillance</term>
<term>Soin</term>
<term>Gynécologie</term>
<term>Obstétrique</term>
<term>Cancer sein</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Purpose: Secondary lymphedema is one of the most frequent long-term side effects affecting up to 30% of all breast cancer patients after local surgical and radiation treatment. The distruction of the lymphatic system results in a progressive and chronic condition with functional impairments and disabilities limiting patients in their daily activities and involving nearly all aspects of their quality of life. The need to improve oncological management to achieve early diagnosis and referral for effective treatment of lymphedema is a major goal of breast cancer health care while survival improves. Method: A systematic consensus process was carried out involving all relevant partners and providers of lymphedema health care to develop a practical documentation concept and make recommendations based on the evidence of clinical studies and current available guidelines. Results: A practical concept for documentation with defined assessment points including the assessment of quality of life parameters with recognised instruments by the patient herself for evaluation and monitoring of lymphedema was developed. Consensus recommendations for the postoperative management, prevention, treatment and follow-up of breast cancer patients together with a clinical algorithm for in- and outpatient care were finalized. Conclusion: With improved survival long-term side effects with a major impact on quality of life become an important endpoint criteria of oncological treatment. The clearly defined documentation concept and the comprehensive recommendations for lymphedema management may assist clinicians and patients to make timely decisions about in- and outpatient health care practice. Patients' compliance with treatment and prevention routines will be as important as ensuring the continuity of care. A longitudinal prospective study evaluating the effectiveness and efficacy of the consensus recommendation is currently being implemented.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0016-5751</s0>
</fA01>
<fA02 i1="01"><s0>GEFRA2</s0>
</fA02>
<fA03 i2="1"><s0>Geburtshilfe Frauenheilkd.</s0>
</fA03>
<fA05><s2>65</s2>
</fA05>
<fA06><s2>10</s2>
</fA06>
<fA08 i1="01" i2="1" l="GER"><s1>Lymphödem bei Mammakarzinom : Regionale Konsensus-Empfehlungen zum postoperativen Management, Prävention, Therapie und Nachsorge</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>ALBERT (U.-S.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>SEIFART (U.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>HEIM (M.-E.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>HÜBNER (J.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>JUNGKUNZ (W.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>PROKEIN (R.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>RICK (O.)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>HOFFMANN (M.)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>ENGENHART-CABILLIC (R.)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>KOPP (I.)</s1>
</fA11>
<fA11 i1="11" i2="1"><s1>WAGNER (U.)</s1>
</fA11>
<fA11 i1="12" i2="1"><s1>KALDER (M.)</s1>
</fA11>
<fA14 i1="01"><s1>Klinik für Gynäkologie, gynäkologische Endokrinologie und Onkologie, Brustzentrum Regio, Universitätsklinikum Giessen und Marburg</s1>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>11 aut.</sZ>
<sZ>12 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Rehabilitations -Klinik Bellevue</s1>
<s2>Bad Soden Salmünster</s2>
<s3>DEU</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Sonnenberg-Klinik, Sooden-Allendorf</s1>
<s3>DEU</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Habichtswald-Klinik</s1>
<s2>Kassel</s2>
<s3>DEU</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Qualitätszirkel Lymphologie Hessen, Leiter des Arbeitskreises Qualitätszirkel der Deutschen Gesellschaft für Lymphologie</s1>
<s2>Friedberg</s2>
<s3>DEU</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>HELIOS William Harvey Klinik</s1>
<s2>Bad Nauheim</s2>
<s3>DEU</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="07"><s1>Klinik Reinhardshöhe</s1>
<s2>Bad Wildungen</s2>
<s3>DEU</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="08"><s1>DRK Krankenhaus</s1>
<s2>Biedenkopf</s2>
<s3>DEU</s3>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="09"><s1>Klinik für Strahlentherapie, Universitätsklinikum Giessen und Marburg</s1>
<s3>DEU</s3>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="10"><s1>Ständige Leitlinien Kommission der Arbeitsgemeinschaft Medizinisch Wissenschaftlicher Fachgesellschaften</s1>
<s3>DEU</s3>
<sZ>10 aut.</sZ>
</fA14>
<fA20><s1>955-965</s1>
</fA20>
<fA21><s1>2005</s1>
</fA21>
<fA23 i1="01"><s0>GER</s0>
</fA23>
<fA24 i1="01"><s0>eng</s0>
</fA24>
<fA43 i1="01"><s1>INIST</s1>
<s2>4872</s2>
<s5>354000135488220040</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2006 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>78 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>06-0003695</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Geburtshilfe und Frauenheilkunde</s0>
</fA64>
<fA66 i1="01"><s0>DEU</s0>
</fA66>
<fA68 i1="01" i2="1" l="ENG"><s1>Lymphedema after breast cancer : Regional consensus recommendations for postoperative management, prevention, treatment and follow-up care</s1>
</fA68>
<fC01 i1="01" l="ENG"><s0>Purpose: Secondary lymphedema is one of the most frequent long-term side effects affecting up to 30% of all breast cancer patients after local surgical and radiation treatment. The distruction of the lymphatic system results in a progressive and chronic condition with functional impairments and disabilities limiting patients in their daily activities and involving nearly all aspects of their quality of life. The need to improve oncological management to achieve early diagnosis and referral for effective treatment of lymphedema is a major goal of breast cancer health care while survival improves. Method: A systematic consensus process was carried out involving all relevant partners and providers of lymphedema health care to develop a practical documentation concept and make recommendations based on the evidence of clinical studies and current available guidelines. Results: A practical concept for documentation with defined assessment points including the assessment of quality of life parameters with recognised instruments by the patient herself for evaluation and monitoring of lymphedema was developed. Consensus recommendations for the postoperative management, prevention, treatment and follow-up of breast cancer patients together with a clinical algorithm for in- and outpatient care were finalized. Conclusion: With improved survival long-term side effects with a major impact on quality of life become an important endpoint criteria of oncological treatment. The clearly defined documentation concept and the comprehensive recommendations for lymphedema management may assist clinicians and patients to make timely decisions about in- and outpatient health care practice. Patients' compliance with treatment and prevention routines will be as important as ensuring the continuity of care. A longitudinal prospective study evaluating the effectiveness and efficacy of the consensus recommendation is currently being implemented.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B20E02</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B12B04</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Lymphoedème</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Lymphedema</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Linfedema</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Tumeur maligne</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Malignant tumor</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Tumor maligno</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Régional</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Regional</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Regional</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Glande mammaire pathologie</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Mammary gland diseases</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Glándula mamaria patología</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Consensus</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Consensus</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Consenso</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Recommandation</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Recommendation</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Recomendación</s0>
<s5>06</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Postopératoire</s0>
<s5>08</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Postoperative</s0>
<s5>08</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Postoperatorio</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Traitement</s0>
<s5>09</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Treatment</s0>
<s5>09</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Conduite à tenir</s0>
<s5>11</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Clinical management</s0>
<s5>11</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Actitud médica</s0>
<s5>11</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Prévention</s0>
<s5>12</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Prevention</s0>
<s5>12</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Prevención</s0>
<s5>12</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Surveillance</s0>
<s5>17</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Surveillance</s0>
<s5>17</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Vigilancia</s0>
<s5>17</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Soin</s0>
<s5>18</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Care</s0>
<s5>18</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Cuidado</s0>
<s5>18</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE"><s0>Gynécologie</s0>
<s5>19</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG"><s0>Gynecology</s0>
<s5>19</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA"><s0>Ginecología</s0>
<s5>19</s5>
</fC03>
<fC03 i1="14" i2="X" l="FRE"><s0>Obstétrique</s0>
<s5>20</s5>
</fC03>
<fC03 i1="14" i2="X" l="ENG"><s0>Obstetrics</s0>
<s5>20</s5>
</fC03>
<fC03 i1="14" i2="X" l="SPA"><s0>Obstétrico</s0>
<s5>20</s5>
</fC03>
<fC03 i1="15" i2="X" l="FRE"><s0>Cancer sein</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="15" i2="X" l="ENG"><s0>Breast cancer</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="15" i2="X" l="SPA"><s0>Cáncer pecho</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Appareil circulatoire pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Cardiovascular disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Aparato circulatorio patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Lymphatique pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Lymphatic vessel disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Linfático patología</s0>
<s5>38</s5>
</fC07>
<fN21><s1>002</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 06-0003695 INIST</NO>
<ET>(Lymphedema after breast cancer : Regional consensus recommendations for postoperative management, prevention, treatment and follow-up care)</ET>
<GT>Lymphödem bei Mammakarzinom : Regionale Konsensus-Empfehlungen zum postoperativen Management, Prävention, Therapie und Nachsorge</GT>
<AU>ALBERT (U.-S.); SEIFART (U.); HEIM (M.-E.); HÜBNER (J.); JUNGKUNZ (W.); PROKEIN (R.); RICK (O.); HOFFMANN (M.); ENGENHART-CABILLIC (R.); KOPP (I.); WAGNER (U.); KALDER (M.)</AU>
<AF>Klinik für Gynäkologie, gynäkologische Endokrinologie und Onkologie, Brustzentrum Regio, Universitätsklinikum Giessen und Marburg/Allemagne (1 aut., 11 aut., 12 aut.); Rehabilitations -Klinik Bellevue/Bad Soden Salmünster/Allemagne (2 aut.); Sonnenberg-Klinik, Sooden-Allendorf/Allemagne (3 aut.); Habichtswald-Klinik/Kassel/Allemagne (4 aut.); Qualitätszirkel Lymphologie Hessen, Leiter des Arbeitskreises Qualitätszirkel der Deutschen Gesellschaft für Lymphologie/Friedberg/Allemagne (5 aut.); HELIOS William Harvey Klinik/Bad Nauheim/Allemagne (6 aut.); Klinik Reinhardshöhe/Bad Wildungen/Allemagne (7 aut.); DRK Krankenhaus/Biedenkopf/Allemagne (8 aut.); Klinik für Strahlentherapie, Universitätsklinikum Giessen und Marburg/Allemagne (9 aut.); Ständige Leitlinien Kommission der Arbeitsgemeinschaft Medizinisch Wissenschaftlicher Fachgesellschaften/Allemagne (10 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Geburtshilfe und Frauenheilkunde; ISSN 0016-5751; Coden GEFRA2; Allemagne; Da. 2005; Vol. 65; No. 10; Pp. 955-965; Abs. anglais; Bibl. 78 ref.</SO>
<LA>Allemand</LA>
<EA>Purpose: Secondary lymphedema is one of the most frequent long-term side effects affecting up to 30% of all breast cancer patients after local surgical and radiation treatment. The distruction of the lymphatic system results in a progressive and chronic condition with functional impairments and disabilities limiting patients in their daily activities and involving nearly all aspects of their quality of life. The need to improve oncological management to achieve early diagnosis and referral for effective treatment of lymphedema is a major goal of breast cancer health care while survival improves. Method: A systematic consensus process was carried out involving all relevant partners and providers of lymphedema health care to develop a practical documentation concept and make recommendations based on the evidence of clinical studies and current available guidelines. Results: A practical concept for documentation with defined assessment points including the assessment of quality of life parameters with recognised instruments by the patient herself for evaluation and monitoring of lymphedema was developed. Consensus recommendations for the postoperative management, prevention, treatment and follow-up of breast cancer patients together with a clinical algorithm for in- and outpatient care were finalized. Conclusion: With improved survival long-term side effects with a major impact on quality of life become an important endpoint criteria of oncological treatment. The clearly defined documentation concept and the comprehensive recommendations for lymphedema management may assist clinicians and patients to make timely decisions about in- and outpatient health care practice. Patients' compliance with treatment and prevention routines will be as important as ensuring the continuity of care. A longitudinal prospective study evaluating the effectiveness and efficacy of the consensus recommendation is currently being implemented.</EA>
<CC>002B20E02; 002B12B04</CC>
<FD>Lymphoedème; Tumeur maligne; Régional; Glande mammaire pathologie; Consensus; Recommandation; Postopératoire; Traitement; Conduite à tenir; Prévention; Surveillance; Soin; Gynécologie; Obstétrique; Cancer sein</FD>
<FG>Appareil circulatoire pathologie; Lymphatique pathologie</FG>
<ED>Lymphedema; Malignant tumor; Regional; Mammary gland diseases; Consensus; Recommendation; Postoperative; Treatment; Clinical management; Prevention; Surveillance; Care; Gynecology; Obstetrics; Breast cancer</ED>
<EG>Cardiovascular disease; Lymphatic vessel disease</EG>
<SD>Linfedema; Tumor maligno; Regional; Glándula mamaria patología; Consenso; Recomendación; Postoperatorio; Tratamiento; Actitud médica; Prevención; Vigilancia; Cuidado; Ginecología; Obstétrico; Cáncer pecho</SD>
<LO>INIST-4872.354000135488220040</LO>
<ID>06-0003695</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000556 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000556 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:06-0003695
   |texte=   Lymphödem bei Mammakarzinom : Regionale Konsensus-Empfehlungen zum postoperativen Management, Prävention, Therapie und Nachsorge
}}

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

Lymphödem bei Mammakarzinom : Regionale Konsensus-Empfehlungen zum postoperativen Management, Prävention, Therapie und Nachsorge

Lymphödem bei Mammakarzinom : Regionale Konsensus-Empfehlungen zum postoperativen Management, Prävention, Therapie und Nachsorge

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri